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ABSTRACT
Cytochrome b5 (CB5) proteins are small heme-binding proteins, that inﬂuence cytochrome P450 activity.
While only one CB5 isoform is found in mammals, higher plants have several isoforms of these proteins.
The roles of the many CB5 isoforms in plants remain unknown. We hypothesized that CB5 proteins
support the cytochrome P450 enzymes of plant specialized metabolism and found CB5C from Arabidopsis
thaliana to co-express with glucosinolate biosynthetic genes. We characterized the glucosinolate proﬁles
of 2 T-DNA insertion mutants of CB5C, and found that long-chained aliphatic glucosinolates were reduced
in one of the mutant lines – a phenotype that was exaggerated upon methyl-jasmonate treatment. These
results support the hypothesis, that CB5C inﬂuences glucosinolate biosynthesis, however, the mode of
action remains unknown. Furthermore, the mutants differed in their biomass response to methyl
jasmonate treatment. Thereby, our results highlight the varying effects of T-DNA insertion sites, as the 2
analyzed alleles show different phenotypes.
Abbreviations: CB5, cytochrome b5; ER, endoplasmic reticulum; GLS, glucosinolates; LC, long-chained aliphatic;
MeJA, methyl-jasmonate; P450, cytochrome P450; SC, short-chained aliphatic; 4MOI3M, 4-methoxyindole-3-methyl
glucosinolate
KEYWORDS
Arabidopsis; cytochrome
b5; cytochrome P450; glu-
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Introduction
Cytochrome b5 (CB5) proteins are small (»15 kD) heme-bind-
ing proteins, anchored to the endoplasmic reticulum (ER).
These proteins have been studied extensively in animal systems
due to their role in cellular detoxiﬁcation and drug metabo-
lism.1,2,3,4 CB5 proteins interact with ER-anchored cytochrome
P450 (P450) enzymes; a large family of versatile enzymes able
to catalyze the transformation of otherwise inert molecules.5
CB5 proteins inﬂuence P450 enzymes either by supplying elec-
trons – similar to the NADPH-dependent P450 reductases - or
by modulating their activity via physical interaction indepen-
dent of electron donation.6,7 The majority of studies have
focused on mammalian CB5 proteins, whereas CB5 proteins
from other organisms have been examined to a lesser extent. In
contrast to mammals, which have a single copy of the CB5
gene,8 the genomes of higher plants encode multiple CB5 iso-
forms,9 e.g. 6 in the model plant Arabidopsis thaliana10 and 11
in Glycine max (soybean).11 The purpose of the increased num-
ber of CB5 isoforms remains elusive.
As sessile organisms, plants excel in their capability to
synthesize diverse specialized chemicals - e.g., toxins, fra-
grances and pigments – which enable them to interact with,
and adapt to, their ever-changing environment.12 Essential
for this specialized metabolism are P450 enzymes that carry
out central catalytic steps in several of these specialized bio-
synthetic pathways.13,14 The number of these enzymes are
widely expanded in higher plants, with A. thaliana having
more than 240.15 Plants may therefore have evolved a larger
number of CB5 isoforms to keep up with the increased
number of P450s.16,17 A connection between CB5 proteins
and specialized plant metabolism was found in petunia,
where discoloration of the ﬂower petals was observed in a
CB5 knock-out mutant.18 The change in ﬂower color coin-
cided with a decrease in anthocyanins and a decrease in the
activity of the biosynthetic P450, ﬂavonoid 3, 5-hydroxylase,
indicating that this enzyme requires CB5 for full enzymatic
activity. Further evidence for a role of CB5 proteins in spe-
cialized metabolism comes from the biosynthesis of artemi-
sinic acid – the precursor for the anti-malarial drug,
artemisinin. Upon heterologous expression of the artemi-
sinic acid biosynthetic pathway (including a P450) from
Artimisia annua, co-expression of a CB5 resulted in higher
levels of artemisinic acid.19 These ﬁndings suggest that CB5
proteins can be critical for metabolic efﬁciency, possibly
through interactions with the P450 enzymes.
A. thaliana produces glucosinolates (GLS) as their major
class of specialized metabolites involved in plant defense.20,21
P450s carry out essential enzymatic steps in the GLS biosyn-
thetic pathway. Based on the idea that CB5 proteins might be
involved in plant specialized metabolism through interactions
with P450s, we hypothesized that a CB5 protein plays a role for
the efﬁciency of this pathway.22 In this study, we investigated
the role of the CB5 isoform C, which co-expresses with the
GLS pathway in A. thaliana. We characterized GLS proﬁles of
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2 T-DNA insertional mutants of CB5C in the presence and
absence of the GLS-inducing hormone methyl-jasmonate
(MeJA). Our results show that CB5C affects GLS proﬁles by
inﬂuencing especially long-chained aliphatic (LC) GLS.
Results
Co-expression analysis revealed that only one of the 6 A. thaliana
CB5 genes – CB5C (also referred to as CYB5-1) 23 – co-expresses
with the GLS biosynthesis genes (Table 1). We obtained 2 T-DNA
insertion lines, cb5c-1 and cb5c-2 (Fig. 1) and analyzed the expres-
sion levels of CB5C (Fig. 2). As previously reported, cb5c-2 is a
knock-down mutant,23 and also cb5c-1 shows reduced transcript
levels compared to wildtype (WT).
Analysis bymass-spectrometry enabled quantiﬁcation of 15 dif-
ferent GLS in individual seedlings. Total levels of GLS were similar
in mutants and WT plants (Table 2, Table S1). However, the
mutants showed differences in the levels of individual GLS. cb5c-1
showed signiﬁcantly reduced levels of the LC GLS 7-methylsulﬁ-
nylheptyl and 8-methylsulﬁnyloctyl GLS. By contrast, cb5c-2
showed reduced levels of the seed-derived 3-benzoyloxypropyl
GLS. Common for both mutants was an increased accumulation of
the short-chained aliphatic (SC) 4-methylthiobutyl GLS (pD 0.072
and 0.012 for cb5c-1 and cb5c-2, respectively).
As GLS levels are inducible upon application of exogenous
jasmonate,22,24 we treated the plants with methyl-jasmonate
(MeJA) to assess whether this would exaggerate the subtle
chemotypes of cb5c-1 and cb5c-2, thus revealing a potential
condition-speciﬁc role of CB5C. MeJA treatment led to an
increase in almost all measured GLS, and indeed resulted in
more pronounced differences in GLS between genotypes
(Table 2). Interestingly, MeJA-treated WT plants showed an
increase in 3-benzoyloxypropyl and 4-benzoyloxybutyl GLS.
These GLS originate from the seed, but are not de novo synthe-
sized in the seedlings.25 A similar – but less pronounced –
increase upon MeJA, was observed for the cb5c-2 mutant, but
no signiﬁcant increase was found in cb5c-1.
In the MeJA-treated cb5c-1 mutant LC GLS continued to be
lower compared to WT, but the decrease now involved all LC
GLS. In addition, one SC GLS (4-benzoyloxybutyl GLS) was
signiﬁcantly lower in cb5c-1 upon MeJA treatment compared
to the WT. Similarly, in cb5c-2, we found the levels of 3-ben-
zoyloxypropyl GLS to be lower than WT when treated with
MeJA. In this mutant line, the 4-methoxyindol-3-ylmethyl GLS
(4MOI3M) also showed a decrease (Table 2).
By visual inspection of the plates, we noticed a difference in
growth between the genotypes in response to MeJA treatment.
Quantiﬁcation of this phenotype revealed a difference in
growth between genotypes upon hormone treatment, whereas
Table 1. Genes co-expressing with A. thaliana CB5C
Locus Alias (Short description) Role in glucosinolate biosynthesis MR
At2g46650 CB5C 0
At4g39940 APK2 1
At1g18590 SOT17 aliphatic and indolyl 2
At2g20610 SUR1 aliphatic and indolyl 3.5
At5g44720 sulfurase 4.1
At2g14750 AKN1 4.2
At5g63980 SUPO1 4.7
At5g07460 PMSR2 6.3
At4g30530 GGP1 aliphatic and indolyl 6.5
At3g58990 IPMI1 aliphatic 6.6
At3g03190 GSTF11 aliphatic 7.1
At1g24100 UGT74B1 indolyl 7.8
At3g23570 alpha/beta-Hydrolases 9.5
At4g39950 CYP79B2 indolyl 9.5
At4g12030 BAT5 aliphatic 9.5
At1g74090 SOT18 aliphatic 10
At4g13770 REF2 10.2
At2g43100 IPMI2 aliphatic 10.4
At2g22330 CYP79B3 indolyl 11.4
At1g24625 ZFP7 12.1
At3g19710 BCAT4 aliphatic 13
At2g30860 GSTF9 indolyl 13.2
At1g62560 FMO GS-OX3 aliphatic 14
At1g65860 FMO GS-OX1 aliphatic 14.4
At1g74100 SOT16 indolyl 14.8
At4g14680 APS3 15
At2g31790 transferase 16.9
At5g23010 MAM1 aliphatic 17.1
At5g01500 TAAC 17.2
At1g78370 GSTU20 aliphatic 17.3
At4g31500 SUR2 indolyl 17.7
At5g60890 MYB34 Indolyl 17.7
The top 31 genes co-expressing with CB5C. MR is a co-expression value used by the
ATTED-II database. Enzymes involved in glucosinolate biosynthesis are highlighted
in bold.
Figure 1. Sequence structure of CB5C and mutants. a) Gene structure of A. thaliana
CB5C, showing the T-DNA insertion sites for the 2 mutants (cb5c-1 and cb5c-2).
Black boxes depict exons; white boxes indicate introns and untranslated regions.
b) Sequence comparison between the protein products of WT and cb5c-1. The N-
terminal heme-binding domain (gray), the C-terminal transmembrane helix (black)
and the additional domain of the cb5c-1 mutant.
Figure 2. Expression levels of CB5C. The three genotypes (WT, cb5c-1 and cb5c-2)
were analyzed for CB5C expression. Bar graphs display the mean expression (nor-
malized to WT levels) and error-bars display the standard deviation of 3 indepen-
dent biological replicates for each genotype.
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no signiﬁcant difference between untreated plants was
observed. WT and cb5c-1 plants showed decreased weight
upon treatment, whereas the weight of cb5c-2 was unaffected
(Fig. 3).
Discussion
We analyzed GLS levels of 2 T-DNA mutants of the CB5C gene.
The two mutants have different T-DNA insertion sites. The
cb5c-1 knock-down mutant has an insertion within the coding
sequence of the CB5C gene, causing a disruption of the reading
frame that is likely to result in a recombinant protein with 39
new C-terminal residues (Fig. 1). As the residues C-terminal to
the transmembrane helix determine the localization of CB5
proteins in A. thaliana,10 an altered amino acid sequence at the
C-terminus could result in mislocalization of the CB5C protein.
The cb5c-2 mutant carries a T-DNA insertion in the 30-
untranslated region of the gene, classifying it as a “knock-
about” mutant (Fig. 1).26 Although the 2 mutants show compa-
rable decreases in transcript levels (Fig. 2), the corresponding
proteins might differ fundamentally in their C-terminal amino
acid sequence. The recombinant CB5C-1 mutant protein likely
mislocalizes, whereas the cb5c-2 mutant encodes the native
CB5C protein, with full functionality. This may render the phe-
notypic effects of the T-DNA insertions very different, although
CB5C transcript levels are comparable in the 2 mutant lines.
Both mutants show subtle but distinct alterations in the lev-
els of individual GLS. Treatment with MeJA exaggerates the
differences between WT and mutants. Prolonged treatment of
A. thaliana seedlings with exogenous MeJA – as done in these
experiments - does likely not reﬂect physiological conditions,
but allows us to induce GLS levels, 27 and provoke a stronger
phenotype. These ﬁndings support our hypothesis that CB5C
inﬂuences GLS biosynthesis, in a condition-speciﬁc manner.
The function of CB5C does not seem to be essential for GLS
biosynthesis, but it affects accumulation of particularly LC
GLS, especially when induced by MeJA treatment. The decrease
in almost exclusively LC GLS seen for the cb5c-1 mutant sug-
gests speciﬁcity in the function of CB5C and potentially links
the gene to the CYP79F enzymes that catalyze a key step in the
biosynthetic step of speciﬁcally LC GLS.28,29 We observed no
differences in LC GLS in the cb5c-2 mutant, where we antici-
pate that CB5C is properly localized. Here, the residual expres-
sion might be able to sustain its role in supporting GLS
biosynthesis, whereas the cb5c-1 mutant protein may be mislo-
calized and therefore non-functional. Another discrepancy
between the 2 mutants is their relatively low levels of the seed-
speciﬁc 3-benzoyloxypropyl and 4-benzoyloxybutyl GLS. Upon
MeJA treatment WT plants accumulate more of these GLS,
indicating less GLS turnover. The cb5c-1 did not show a
Table 2. Glucosinolate levels in seedlings of the cb5c mutants (nmol/g FW).
Genotype Treatment WT ctrl cb5c-1 ctrl cb5c-2 ctrl WT MeJA cb5c-1 MeJA cb5c-2 MeJA
Total GLS 1673 § 142 1307 § 139 1438 § 143 4162 § 364 3615 § 295 3210 § 196ø
Short-chained aliphatic GLS 267 § 20 258 § 27 276 § 30 390 § 33 356 § 38 385 § 37
3-methylsulﬁnylpropyl 11 § 1 12 § 2 11 § 1 22 § 3 21 § 5 24 § 5
3-hydroxypropyl 4 § 1 4 § 1 3 § 1 3 § 1 3 § 1 2 § 1
3-benzoyloxypropyl 28 § 3 31 § 3 19 § 2 37 § 3 38 § 3 25 § 2
4-methylthiobutyl 30 § 4 79 § 12ø 79 § 14 73 § 11 88 § 15 93 § 14
4-methylsulﬁnylbutyl 111 § 12 103 § 13 103 § 11 154 § 20 139 § 28 155 § 26
4-hydroxybutyl 37 § 3 33 § 5 32 § 4 37 § 3 33 § 4 32 § 3
4-benzoyloxybutyl 53 § 3 38 § 6ø 45 § 5 71 § 4 48 § 6 58 § 4ø
5-methylsulﬁnylpentyl 21 § 2 18 § 1 18 § 1 33 § 3 28 § 4 29 § 4
Long-chained aliphatic GLS 258 § 34 174 § 28ø 194 § 27 767 § 52 554 § 56 731 § 41
7-methylthioheptyl 34 § 5 30 § 3 34 § 4 98 § 8 63 § 7 87 § 5
7-methylsulﬁnylheptyl 51 § 6 30 § 4 36 § 4ø 82 § 5 60 § 6 80 § 7
8-methylthiooctyl 53 § 9 65 § 6 48 § 7 276 § 20 195 § 25 250 § 15
8-methylsulﬁnyloctyl 135 § 17 98 § 15 109 § 14 312 § 22 242 § 22 314 § 22
Indolyl GLS 1127 § 103 879 § 94 952 § 97 2973 § 328 2699 § 250 2066 § 192ø
Indol-3-ylmethyl 195 § 13 186 § 17 159 § 15 627 § 78 566 § 108 394 § 68ø
4-methoxyindol-3-ylmethyl 131 § 12 103 § 10 108 § 11 648 § 41 610 § 53 478 § 38
N-methoxyindol-3-ylmethyl 801 § 83 655 § 73 684 § 76 1698 § 355 1523 § 289 1193 § 218
Values are given as mean § s.e.m.
p < 0.01 p < 0.05 øp < 0.1 different from WT via pairwise t-test, n D 30. Control treatment (ctrl). Methyl-jasmonate (MeJA). Glucosinolates (GLS).
See Table S1 for the ANOVA results.
Figure 3. Biomass response to MeJA. Biomass responses of 10-day-old seedlings of
the 3 genotypes (WT, cb5c-1 and cb5c-2). The weight of seedlings treated with
methyl-jasmonate (MeJA) was normalized to the weight of untreated seedlings
(ctrl). Different letters refer to statistical groupings (pairwise t-test as post-hoc, p <
0.05, n D 30). See Table S1 for the ANOVA table.
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signiﬁcant change in these 2 GLS upon MeJA treatment,
whereas cb5c-2 showed an increase comparable to - but less
pronounced than - WT plants. This indicates that the effect of
CB5C on GLS proﬁles results from increase in turnover, as is
seen for these seed-speciﬁc glucosinolates.
The different phenotypic consequences of the 2 T-DNA
insertions are further illustrated by the differences in biomass
response to MeJA treatment (Fig. 3). Exogenously applied
MeJA reduces seedling biomass,30-32 but strikingly, seedlings of
the cb5c-2 mutants did not show this response. In comparison,
WT and cb5c-1 mutants showed reduced growth upon MeJA
treatment. Noticeably, A. thaliana CB5 proteins interact with a
series of other proteins than P450s such as 1) a plasma mem-
brane-localized sucrose transporter,23 2) several enzymes
involved in fatty acid metabolism11,33 and 3) the ethylene
response regulator RTE1.34 This – together with our ﬁndings –
suggests that CB5C could play a broader physiological role, in
addition to directly inﬂuencing GLS metabolism.
Methods
Co-expression analysis
Genes co-expressing with CB5C were identiﬁed using the
ATTED-II database (http://atted.jp/).35
Plant lines and growth conditions
Two T-DNA insertion lines targeting CB5C (AT2G46650) –
cb5c-1 (SALK_027748C) and cb5c-2 (cyb5-1; SALK_065187) -
were acquired from the Nottingham Arabidopsis Stock Center
(NASC). The cb5c-1 line was homozygous. The cb5c-2 line was
heterozygous; a homozygous line and a segregating wildtype
(referred to as WT) were obtained from this heterozygote.
Plants were germinated and grown on MS (Murashige and
Skoog medium including vitamins; M0222, Duchefa) agar
plates with 1% sucrose. For hormone treatment, the medium
was supplemented with 10 mM MeJA (392707–5ML,Sigma-
Aldrich). Seeds were sterilized by incubating in 70% (v/v) etha-
nol, 0.05 % (v/v) Triton X-100 for 5 min and washing in 70%
(v/v) ethanol. The air-dried seeds were plated and cold-strati-
ﬁed for 24 hours at 4C in the dark. Seedlings were grown for
10 d at 20C under 16 hours of light with an intensity of 110–
140 mE.
Quantitative RT-PCR
RNA was extracted using TRIzol® reagent (Invitrogen 15596–
018). For each biological repetition, 3 seedlings were pooled
and placed in a tube with 0.5 mL TRIzol and a chrome ball.
Samples were homogenized in a Retch Mixer Mill 303 at 30 Hz
for 30 sec. Samples were then incubated 5 min at room temper-
ature. 0.2 mL chloroform was added and the samples mixed
before being centrifuged for 15 min at 12.000x g at 4C. The
upper phase was collected and mixed with an equal volume of
cold isopropanol. The samples were kept on ice for 30 min
before being centrifuged for 10 min at 15.000x g at 4C. The
resulting pellet was washed with 75 % ethanol and centrifuged
for 5 min at 7.500x g at 4C. Supernatant was removed and the
resulting pellet was air-dried before resuspension in 20 mL
nuclease free water. The extracted RNA was DNase treated
using DNaseI (AMPDK1-1KT, Sigma-Aldrich) according to
manufactures instructions. 1 mg of RNA was reverse tran-
scribed into cDNA with the iScript cDNA synthesis kit
(#1708891, Bio-Rad) following the manufactures instructions.
qRT-PCR was performed using DyNAmo Flash SYBR Green
qPCR Kit (F-415L, Thermo Scientiﬁc) and the following primers
to quantify CB5C expression: 50-AGCACTTTCATGGAC-
GAACA-‘3 and 50-TTGGCATCTTTGCTATGGTTC-‘3. PEX4/
UBC21 (AT5G25760)36 was used as reference gene using the fol-
lowing primers: 50- CTGAGCCGGACAGTCCTCTTAACTG-‘3
and 50-CGGCGAGGCGTGTATACATTTGTG-‘3. Two rounds
of technical replicates were run, each including all 3 biological
replicates. The CT values for CB5C were normalized to PEX4/
UBC21 – taking primer efﬁciencies into account (close to 1 for
both primer sets). Finally, the CB5C expression values of each
mutant were further normalized to WT.
GLS and biomass analysis
GLS were extracted from single 10-day-old seedlings. The
extraction was performed according to Andersen et al.37 using
1 nmol p-hydroxybenzyl GLS as internal standard. Quantiﬁca-
tion was performed via liquid chromatography coupled to
mass-spectrometry according to Jensen et al.38 Two indepen-
dent rounds of experiments were performed with 15 seedlings
for each combination of genotype and treatment per round –
seedlings of these experiments were weighed individually on a
scale with sub-milligram sensitivity. Prior to any statistical anal-
ysis, the weight of MeJA-treated seedlings were normalized to
the mean weight of the corresponding untreated seedlings –
yielding the biomass response values. Statistical analysis of
biomass response and GLS levels was performed across experi-
mental rounds via ANOVA, using the following linear models:
GLS D TREATMENT C GENOTYPE C EXPERIMENT C
EXPERIMENT:GENOTYPE C TREATMENT:GENOTYPE C
EXPERIMENT:TREATMENT and Biomass response D geno-
type C experiment C genotype:experiment. Holm-corrected
pairwise t-tests were used for post hoc testing.
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